effects of semaglutide on pregnancy So-Called “Ozempic Babies” Raise Questions About Unintended GLP-1 Agonists Impact of semaglutide exposure on

These medications have had a significant impact on weight...

Currently, semaglutide (Novo Nordisk) is approved for the treatment of overweight and obesity leading to a mean weight loss of 15% after 68 weeks, the researchers wrote.

Track doses, manage side effects, reduce food noise, and build habits that actually stick.

Exposures New users of GLP-1RA were separately compared with new users of dipeptidyl peptidase-4 inhibitors (DPP4i) and sodium-glucose cotransporter 2 inhibitors (SGLT2i), using 1:1 propensity score matching to adjust for differences in patient characteristics

Beyond these well-known effects, an interesting aspect of this drug is its antiatherogenic activity, which should be further explored in clinical practice

Each pen contains: Total Volume: 2.4 mL